Search

everythinglearnresearchcommunity

for

Search:↓

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

New tools and criteria have been developed to better assess and treat pediatric lupus.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

A 16-year-old girl with lupus symptoms improved with treatment despite negative ANA tests.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

A multidisciplinary approach is essential for effectively managing cutaneous lupus erythematosus.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Early detection and targeted management are crucial for better outcomes in systemic lupus erythematosus.

Low free thyroxine (FT4) is common in young lupus patients and needs quick diagnosis and treatment.

SLE and DM can coexist but are rare and need careful evaluation.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Early diagnosis and coordinated care are crucial for managing lupus effectively.

Educating primary care doctors and improving referrals to rheumatologists can reduce delays in treating lupus patients.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Hydroxychloroquine may help delay skin damage in lupus patients.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.